{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T23:17:29Z","timestamp":1782775049687,"version":"3.54.5"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Obstetrics &amp; Gynaecology"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.bpobgyn.2019.10.002","type":"journal-article","created":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T13:37:16Z","timestamp":1571837836000},"page":"85-96","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Assisted reproductive technologies for women with rheumatic AID"],"prefix":"10.1016","volume":"64","author":[{"given":"Michael D.","family":"Lockshin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpobgyn.2019.10.002_bib1","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2018-000280","article-title":"SLE: reconciling heterogeneity","volume":"6","author":"Lockshin","year":"2019","journal-title":"Lupus Sci & Med"},{"key":"10.1016\/j.bpobgyn.2019.10.002_bib2","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.bpobgyn.2019.10.002_bib3","series-title":"American College of Rheumatology reproductive health in rheumatic and musculoskeletal diseases guideline","author":"Sammaritano","year":"2019"},{"issue":"3","key":"10.1016\/j.bpobgyn.2019.10.002_bib4","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/annrheumdis-2016-209770","article-title":"EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and\/or antiphospholipid syndrome","volume":"76","author":"Andreoli","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.bpobgyn.2019.10.002_bib5","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1056\/NEJM199101173240303","article-title":"A\u00a0randomized study of the effect of withdrawing hydroxychloroquine sulfate in systemic lupus erythematosus","volume":"324","year":"1991","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bpobgyn.2019.10.002_bib7","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1056\/NEJMra1705454","article-title":"Diagnosis and management of the antiphospholipid syndrome","volume":"378","author":"Garcia","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.bpobgyn.2019.10.002_bib8","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1002\/art.1780371109","article-title":"Systemic lupus erythematosus induced by ovulation induction treatment","volume":"37","author":"Ben-Chetrit","year":"1994","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.bpobgyn.2019.10.002_bib9","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/1529-0131(200003)43:3<550::AID-ANR10>3.0.CO;2-Y","article-title":"Ovulation induction and in\u00a0vitro fertilization in systemic lupus erythematosus and antiphospholipid syndrome","volume":"43","author":"Guballa","year":"2000","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.bpobgyn.2019.10.002_bib10","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1053\/sarh.2002.37212","article-title":"Importance of planning ovulation induction therapy in systemic lupus erythematosus and antiphospholipid syndrome: a single center retrospective study of 21 cases and 114 cycles","volume":"32","author":"Huong","year":"2002","journal-title":"Semin Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.bpobgyn.2019.10.002_bib11","doi-asserted-by":"crossref","first-page":"613","DOI":"10.3899\/jrheum.160462","article-title":"In\u00a0vitro fertilization in 37 women with systemic lupus erythematosus or antiphospholipid syndrome: a series of 97 procedures","volume":"44","author":"Orquevaux","year":"2017","journal-title":"J\u00a0Rheumatol"},{"issue":"5","key":"10.1016\/j.bpobgyn.2019.10.002_bib12","doi-asserted-by":"crossref","first-page":"547","DOI":"10.3899\/jrheum.170064","article-title":"Safety and efficacy of in\u00a0vitro fertilization in women with systemic lupus erythematosus and antiphospholipid syndrome","volume":"44","author":"Genest","year":"2017","journal-title":"J\u00a0Rheumatol"},{"issue":"4","key":"10.1016\/j.bpobgyn.2019.10.002_bib13","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s10067-007-0812-x","article-title":"Clinical significance of anti-Ro antibodies in rheumatoid arthritis","volume":"27","author":"Schneeberger","year":"2008","journal-title":"Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2019.10.002_bib14","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1161\/CIRCULATIONAHA.111.089268","article-title":"Maternal use of hydroxychloroquine is associated with a reduced risk of recurrent anti-SSA\/Ro-antibody\u2013associated cardiac manifestations of neonatal lupus","volume":"126","author":"Izmirly","year":"2012","journal-title":"Circulation [Internet]"},{"issue":"2","key":"10.1016\/j.bpobgyn.2019.10.002_bib15","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s11926-006-0049-8","article-title":"The prevalence and clinical significance of antiphospholipid antibodies in rheumatoid arthritis","volume":"8","author":"Olech","year":"2006","journal-title":"Curr Rheumatol Rep"},{"issue":"5","key":"10.1016\/j.bpobgyn.2019.10.002_bib16","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1002\/art.27358","article-title":"Birth outcomes in women who have taken leflunomide during pregnancy","volume":"62","author":"Chambers","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"13","key":"10.1016\/j.bpobgyn.2019.10.002_bib17","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1182\/blood-2018-04-848333","article-title":"Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome","volume":"132","author":"Pengo","year":"2018","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.bpobgyn.2019.10.002_bib18","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.thromres.2007.05.023","article-title":"The \u201cART\u201d of thromboembolism: a review of assisted reproductive technology and thromboembolic complications","volume":"121","author":"Chan","year":"2008","journal-title":"Thromb Res [Internet]"},{"issue":"3","key":"10.1016\/j.bpobgyn.2019.10.002_bib19","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/GCO.0b013e328329c2b8","article-title":"The \u2018ART\u2019 of thrombosis: a review of arterial and venous thrombosis in assisted reproductive technology","volume":"21","author":"Chan","year":"2009","journal-title":"Curr Opin Obstet Gynecol [Internet]"},{"issue":"8","key":"10.1016\/j.bpobgyn.2019.10.002_bib20","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1111\/j.1538-7836.2006.02062.x","article-title":"Artificial reproductive technology and the risk of venous thromboembolic disease","volume":"4","author":"Nelson","year":"2006","journal-title":"J\u00a0Thromb Haemost [Internet]"},{"key":"10.1016\/j.bpobgyn.2019.10.002_bib21","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.thromres.2018.05.006","article-title":"Effects of multiple inherited and acquired thrombophilia on outcomes of in-vitro fertilization","volume":"167","author":"Di Nisio","year":"2018","journal-title":"Thromb Res"},{"issue":"10","key":"10.1016\/j.bpobgyn.2019.10.002_bib22","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1002\/art.27575","article-title":"Passively acquired anti-SSA\/Ro antibodies are required for congenital heart block following ovo donation but maternal genes are not","volume":"62","author":"Brucato","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.bpobgyn.2019.10.002_bib23","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1001\/jamadermatol.2016.0001","article-title":"Cutaneous neonatal lupus arising in an infant conceived from an oocyte donation pregnancy","volume":"152","author":"Chiou","year":"2016","journal-title":"JAMA Dermatol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2019.10.002_bib24","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2015-000084","article-title":"Patients with overlap autoimmune disease differ from those with 'pure' disease","volume":"2","author":"Lockshin","year":"2015","journal-title":"Lupus Sci Med"},{"issue":"10","key":"10.1016\/j.bpobgyn.2019.10.002_bib25","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1136\/annrheumdis-2014-205383","article-title":"Fertility in women with rheumatoid arthritis: influence of disease activity and medication","volume":"74","author":"Brouwer","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.bpobgyn.2019.10.002_bib26","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3899\/jrheum.180176","article-title":"Fertility and ovarian Reserve among women with rheumatoid arthritis","volume":"46","author":"Eudy","year":"2019","journal-title":"J\u00a0Rheumatol"},{"issue":"2","key":"10.1016\/j.bpobgyn.2019.10.002_bib27","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/acr2.1016","article-title":"Pregnancy, periods, and \u201cthe pill\u201d: exploring the reproductive experiences of women with inflammatory arthritis","volume":"1","author":"Talabi","year":"2019","journal-title":"ACR Open Rheum"},{"issue":"3","key":"10.1016\/j.bpobgyn.2019.10.002_bib28","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.medcli.2015.04.032","article-title":"Protective effect of GnRH analogues on the reproductive capacity of women with neoplasia or autoimmune disease who require chemotherapy. Final results of a phase ii clinical trial","volume":"146","author":"Gris-Mart\u00ednez","year":"2016","journal-title":"Med Cl\u00ednica"},{"issue":"10","key":"10.1016\/j.bpobgyn.2019.10.002_bib29","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1093\/rheumatology\/ken293","article-title":"Tan SL Fertility preservation treatment for young women with autoimmune diseases facing treatment with gonadotoxic agents","volume":"47","author":"Elizur","year":"2008","journal-title":"Rheumatology"},{"issue":"10","key":"10.1016\/j.bpobgyn.2019.10.002_bib30","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1007\/s10815-015-0575-2","article-title":"Outcomes of ovarian stimulation after treatment with chemotherapy","volume":"32","author":"Chan","year":"2015","journal-title":"J\u00a0Assist Reprod Genet"},{"issue":"11\u201312","key":"10.1016\/j.bpobgyn.2019.10.002_bib31","first-page":"591","article-title":"Severe ovarian hyperstimulation syndrome in patients with autoimmune disorders: a report of two cases","volume":"59","author":"Kilpatrick","year":"2014","journal-title":"J\u00a0Reprod Med"},{"issue":"5","key":"10.1016\/j.bpobgyn.2019.10.002_bib32","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1002\/ana.23745","article-title":"Increase in multiple sclerosis activity after assisted reproduction technology","volume":"72","author":"Correale","year":"2012","journal-title":"Ann Neurol"},{"issue":"7","key":"10.1016\/j.bpobgyn.2019.10.002_bib33","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1016\/j.fertnstert.2009.08.062","article-title":"Prevalence of antiphospholipid antibodies among women experiencing unexplained infertility and recurrent implantation failure","volume":"93","author":"Sauer","year":"2010","journal-title":"Fertil Steril"},{"issue":"6","key":"10.1016\/j.bpobgyn.2019.10.002_bib34","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1093\/humrep\/14.6.1461","article-title":"Cumulative pregnancy and live birth rates in women with antiphospholipid antibodies undergoing assisted reproduction","volume":"14","author":"Eldar-Geva","year":"1999","journal-title":"Hum Reprod"},{"issue":"3","key":"10.1016\/j.bpobgyn.2019.10.002_bib35","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1136\/annrheumdis-2018-214619","article-title":"Decreased chance of a live born child in women with rheumatoid arthritis after assisted reproduction treatment: a nationwide cohort study","volume":"78","author":"N\u00f8rg\u00e5rd","year":"2019","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.bpobgyn.2019.10.002_bib36","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1034\/j.1600-0897.2001.d01-25.x","article-title":"Successful ovulation induction, conception, and normal delivery after chronic therapy with etanercept: a recombinant fusion anti-cytokine treatment for rheumatoid arthritis","volume":"46","author":"Sills","year":"2001","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.bpobgyn.2019.10.002_bib37","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jri.2017.08.002","article-title":"Association of serum autoantibodies with pregnancy outcome of patients undergoing first IVF\/ICSI treatment: a prospective cohort study","volume":"122","author":"Chen","year":"2017","journal-title":"J\u00a0Reprod Immunol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2019.10.002_bib38","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.8755-8920.2000.430107.x","article-title":"Prednisone and aspirin improve pregnancy rate in patients with reproductive failure and autoimmune antibodies: a prospective study","volume":"43","author":"Geva","year":"2000","journal-title":"Am J Reprod Immunol"},{"issue":"6","key":"10.1016\/j.bpobgyn.2019.10.002_bib39","first-page":"383","article-title":"Results of prednisolone given to improve the outcome of in\u00a0vitro fertilization-embryo transfer in women with antinuclear antibodies","volume":"50","author":"Taniguchi","year":"2005","journal-title":"J\u00a0Reprod Med"},{"issue":"6","key":"10.1016\/j.bpobgyn.2019.10.002_bib40","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/S0015-0282(98)00343-4","article-title":"Prednisolone plus low-dose aspirin improves the implantation rate in women with autoimmune conditions who are undergoing in\u00a0vitro fertilization","volume":"70","author":"Hasegawa","year":"1998","journal-title":"Fertil Steril"},{"issue":"8","key":"10.1016\/j.bpobgyn.2019.10.002_bib41","first-page":"1639","article-title":"Fatal exacerbation of systemic lupus erythematosus after induction of ovulation","volume":"24","author":"Casoli","year":"1997","journal-title":"J\u00a0Rheumatol"},{"issue":"11","key":"10.1016\/j.bpobgyn.2019.10.002_bib42","first-page":"1184","article-title":"Risks of ovulation-induction therapy in systemic lupus erythematosus. We report on four women with systemic lupus erythematosus who developed two types of complications after ovulation-induction therapy for primary or secondary infertility","volume":"35","author":"Huong","year":"1996","journal-title":"Br J Rheumatol"},{"issue":"11","key":"10.1016\/j.bpobgyn.2019.10.002_bib43","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1007\/s10067-010-1426-2","article-title":"A\u00a0case of polymyositis and vasculitis induced by ovulation induction therapy with gonadotropin-releasing hormone","volume":"29","author":"Laz\u00farov\u00e1","year":"2010","journal-title":"Clin Rheumatol"},{"issue":"3","key":"10.1016\/j.bpobgyn.2019.10.002_bib44","doi-asserted-by":"crossref","first-page":"362","DOI":"10.5021\/ad.2011.23.3.362","article-title":"A\u00a0case of assisted reproductive therapy-induced erythema nodosum","volume":"23","author":"Jeon","year":"2011","journal-title":"Ann Dermatol"},{"issue":"3","key":"10.1016\/j.bpobgyn.2019.10.002_bib45","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0015-0282(16)57446-9","article-title":"Massive deep vein thrombosis in a patient with antithrombin III deficiency undergoing ovarian stimulation for in\u00a0vitro fertilization","volume":"63","author":"Kligman","year":"1995","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2019.10.002_bib46","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0049-3848(13)00023-6","article-title":"Venous thrombosis during assisted reproduction: novel risk reduction strategies","volume":"131","author":"Nelson","year":"2013","journal-title":"Thromb Res [Internet]"},{"issue":"6","key":"10.1016\/j.bpobgyn.2019.10.002_bib47","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/j.fertnstert.2009.06.033","article-title":"Ovarian stimulation for ovulation induction and in\u00a0vitro fertilization in patients with systemic lupus erythematosus and antiphospholipid syndrome","volume":"92","author":"Bellver","year":"2009","journal-title":"Fertil Steril"},{"issue":"Suppl 3","key":"10.1016\/j.bpobgyn.2019.10.002_bib48","first-page":"iii38","article-title":"Treating infertility in autoimmune patients","volume":"47","author":"Costa","year":"2008","journal-title":"Rheumatology"},{"issue":"9","key":"10.1016\/j.bpobgyn.2019.10.002_bib49","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1093\/humrep\/det268","article-title":"Emergency IVF for embryo freezing to preserve female fertility: a French multicentre cohort study. French Study Group for Ovarian and Testicular Cryopreservation (GRECOT)","volume":"28","author":"Courbi\u00e8re","year":"2013","journal-title":"Hum Reprod"}],"container-title":["Best Practice &amp; Research Clinical Obstetrics &amp; Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693419301385?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693419301385?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:10:52Z","timestamp":1761498652000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521693419301385"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":48,"alternative-id":["S1521693419301385"],"URL":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2019.10.002","relation":{},"ISSN":["1521-6934"],"issn-type":[{"value":"1521-6934","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assisted reproductive technologies for women with rheumatic AID","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Obstetrics & Gynaecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2019.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}